(EMAILWIRE.COM, August 10, 2019 ) A number of factors, such as the growth in funding for research on electrophoresis techniques, increasing number of research collaborations between market players and academic institutions, increasing use of capillary electrophoresis (CE) with mass spectroscopy (MS), and growing focus on next-generation sequencing research are driving the growth of the electrophoresis market.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=434

“By product, the reagents segment accounted for the largest share of the market in 2016.”

On the basis of product, the reagent segment accounted for the largest share of the global electrophoresis market. This is primarily attributed to the increasing demand for 2D electrophoresis for protein separation for various applications such as biomarker discovery and protein mapping. Over the years, genomic and proteomic technologies have gained significant importance in fields of clinical diagnosis and drug discovery and development.

“By Application, the research segment held the largest market share in 2016.”

Based on application, the research segment accounted for the largest share of this market. Low cost and sensitive approach for DNA sequencing, the major role of electrophoresis in drug discovery, rising use of electrophoresis techniques as a result of growing importance of antibody research in the development of biotherapeutic are the major factors driving the use of electrophoresis, which has boosted the demand for research applications.

Read More@
https://www.marketsandmarkets.com/PressReleases/electrophoresis.asp

“North America dominated the market in 2016.”

North America accounted for the largest share of the electrophoresis market in 2016, followed by Europe and Asia-Pacific. The patent expiration of several blockbuster drugs of major pharmaceutical companies is, in turn, increasing investments for new drug discovery; this is a key market driver in North America.

The prominent players in the global electrophoresis market are Bio-Rad Laboratories (U.S.), GE Healthcare (U.S.), Thermo Fisher Scientific Inc. (U.S.), Danaher Corporation (U.S.), Agilent Technologies (U.S.), Merck Millipore (U.S.), PerkinElmer, Inc. (U.S.), QIAGEN N.V. (Netherlands), Lonza Group Ltd. (Switzerland), Shimadzu Corporation (Japan), Harvard Bioscience, Inc. (U.S.), Sebia Group (U.K.), and C.B.S. Scientific Company, Inc. (U.S.).